MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sacaan, A. I.
Right arrow Articles by Johnson, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sacaan, A. I.
Right arrow Articles by Johnson, K. M.

Spermine enhances binding to the glycine site associated with the N- methyl-D-aspartate receptor complex

AI Sacaan and KM Johnson

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.

Spermine enhanced strychnine-insensitive [3H]glycine binding 3-fold with an EC50 of 27 +/- 3.1 microM. Spermidine and putrescine were without effect, whereas the ethylenediamine analog of spermine had an intermediate effect. Eadie-Hofstee analysis revealed that spermine increased the affinity of glycine for its receptor without a significant change in receptor density. This effect persisted in the presence of glycine or N-methyl-D-aspartate receptor antagonists. Furthermore, spermine produced a leftward shift in the IC50 of glycine agonists in displacing [3H]glycine binding, without altering the IC50 for glycine antagonists. These data indicate that spermine interacts with the glycine receptor through a novel binding site and, further, that spermine can be used to discriminate glycine agonist and antagonist binding.

Volume 36, Issue 6, pp. 836-839, 12/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 StrokeHome page
Th. Els, J. Bruckmann, G. Rohn, M. Daffertshofer, J. S. Monting, R.-I. Ernestus, and M. Hennerici
Spermidine: A Predictor for Neurological Outcome and Infarct Size in Focal Cerebral Ischemia?
Stroke, January 1, 2001; 32(1): 43 - 46.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. C. Harvey and P. Skolnick
Polyamine-Like Actions of Aminoglycosides at Recombinant N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 285 - 291.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. T. McCabe, R. D. Sofia, R. T. Layer, K. A. Leiner, R. L. M. Faull, N. Narang, and J. K. Wamsley
Felbamate Increases [3H]Glycine Binding in Rat Brain and Sections of Human Postmortem Brain
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 991 - 999.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. J. Gallagher, H. Huang, E. R. Grant, and D. R. Lynch
The NR2B-specific Interactions of Polyamines and Protons with the N-Methyl-D-aspartate Receptor
J. Biol. Chem., October 3, 1997; 272(40): 24971 - 24979.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics